Finafloxacin for the treatment of urinary tract infections

September 20, 2015

San Diego, California - September 20, 2015 - Results from a double-blind phase 2 clinical study show that finafloxacin was a more effective and safe option than ciprofloxacin for the treatment of complicated urinary tract infections and acute pyelonephritis. This research is being presented at ASM's 55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC/ICC).

Data from the study shows that patients treated with a five day course of finafloxacin had a higher, more rapid and more sustained level of pathogen eradication and improved clinical outcomes than those treated with the current standard of care, ciprofloxacin taken twice daily for 10 days. "Finafloxacin was found to be both safe and tolerable and could offer physician a viable additional option when treating bacterial infections in future," said David Dally, CEO of MerLion Pharmaceuticals Pte. Ltd.

225 adult Patients diagnosed with cUTI and acute pyelonephritis at 18 sites in Poland and Germany were randomized to receive 800 mg finafloxacin once daily either for a total of 5 or 10 days, or 400 mg (oral)/500 mg (iv) ciprofloxacin twice daily for 10 days. Physicians could switch from the initial intravenous to oral administration and release the patients from hospital after day 3.

Finafloxacin dosed for 5 days was as efficient as finafloxacin dosed for 10 days in a combined evaluation of the clinical and microbiological response with efficacy rates of 70% and 68% on day 17 of the study. Both finafloxacin dosing regimens were more efficient than the treatment with ciprofloxacin for 10 days resulting in 57% efficacy. The short 5 day treatment period with finafloxacin did not result in an increased rate of relapses when compared to both 10 day treatment regimens in this study.

Furthermore, an interim evaluation on day 3 of the study revealed that finafloxacin eradicated pathogens more quickly than ciprofloxacin (89% vs. 79%). This rapid antibacterial activity of finafloxacin was not affected by urine pH, with comparable activity at acidic, neutral and basic conditions whereas ciprofloxacin eradicated pathogens less efficiently in patients with acidic urine.

"In contrast to ciprofloxacin, finafloxacin also showed a very rapid antimicrobial effect against ciprofloxacin-resistant pathogens and ESBL producing bacteria," said David Dally. Resistance to fluoroquinolones and ESBL producing bacteria that cause UTIs in particular are an increasing health problem.

Urinary tract infections (UTIs) are among the most prevalent infectious diseases in ambulatory and hospitalized populations, with a substantial financial burden on society, causing more than 7 million annual physician visits in the USA.

The results of this phase 2 clinical study were presented by MerLion Pharmaceuticals ("MerLion"), a biopharmaceutical company based in Singapore and Berlin.
This research was presented as part of ASM's Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) being held from September 17-21, 2015 in San Diego, California.

The American Society for Microbiology is the largest single life science society, composed of over 39,000 scientists and health professionals. ASM's mission is to promote and advance the microbial sciences.

ASM advances the microbial sciences through conferences, publications, certifications and educational opportunities. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry and clinical settings. Additionally, ASM promotes a deeper understanding of the microbial sciences to diverse audiences.

American Society for Microbiology

Related Urinary Tract Infections Articles from Brightsurf:

Risk of sepsis greatest for patients with frailty, older age or urinary tract infections
Patients with frailty, older age and urinary tract infections (UTIs) are at greatest risk of developing sepsis following infection consultations in primary care, research has found.

Non-invasive biomarkers to diagnose infant urinary tract obstruction
One in every 500 babies is born with ureteropelvic junction obstruction (UPJO), an obstruction of the ureter that prevents urine from flowing from one or both of the kidneys into the bladder.

How the body fights off urinary tract infections
Some people are better protected than others against urinary tract infections.

Health: Vegetarian diet linked with lower risk of urinary tract infections
A vegetarian diet may be associated with a lower risk of urinary tract infections (UTIs), a study in Scientific Reports suggests.

Smartphone cameras can speed up urinary tract infection diagnosis
Biological Engineers at the University of Bath have developed a test that could help medics quickly diagnose urinary tract infections (UTIs), using a normal smartphone camera.

Better tests needed for urinary tract infections
Doctors urgently need a fast and accurate test for diagnosing urinary tract infections (UTIs) to reduce overprescribing of antibiotics, according to health researchers.

Urinary tract and other infections may trigger different kinds of stroke
Several infections have been identified as possible stroke triggers, with urinary tract infections showing the strongest link with ischemic stroke.

More monitoring needed to reduce post-hospitalization urinary tract infections
Broader monitoring of patients is needed to reduce the number of people who develop a urinary tract infection after being discharged from the hospital, new research suggests.

Study details bacteria's role in recurrent urinary tract infections
A new finding by researchers at The University of Texas at Dallas and UT Southwestern Medical Center shows that several species of bacteria reside in bladder tissue of postmenopausal women who experience recurrent urinary tract infections (RUTIs).

Study sheds new light on urinary tract infections in postmenopausal women
A UT Southwestern study suggests why urinary tract infections (UTIs) have such a high recurrence rate in postmenopausal women -- several species of bacteria can invade the bladder walls.

Read More: Urinary Tract Infections News and Urinary Tract Infections Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to